Cargando…
In silico-guided sequence modifications of K-ras epitopes improve immunological outcome against G12V and G13D mutant KRAS antigens
BACKGROUND: Somatic point substitution mutations in the KRAS proto-oncogene primarily affect codons 12/13 where glycine is converted into other amino acids, and are highly prevalent in pancreatic, colorectal, and non-small cell lung cancers. These cohorts are non-responsive to anti-EGFR treatments,...
Autores principales: | Ng, Allan Wee Ren, Tan, Pei Jun, Hoo, Winfrey Pui Yee, Liew, Dek Shen, Teo, Michelle Yee Mun, Siak, Pui Yan, Ng, Sze Man, Tan, Ee Wern, Abdul Rahim, Raha, Lim, Renee Lay Hong, Song, Adelene Ai Lian, In, Lionel Lian Aun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055689/ https://www.ncbi.nlm.nih.gov/pubmed/30042874 http://dx.doi.org/10.7717/peerj.5056 |
Ejemplares similares
-
K-Ras Peptide Mimotope Induces Antigen Specific Th1 and B-Cell Immune Responses against G12A-Mutated K-Ras Antigen in Balb/c Mice
por: Siak, Pui Yan, et al.
Publicado: (2021) -
Effect of Secretion Efficiency of Mutant KRAS Neoantigen by Lactococcus lactis on the Immune Response of a Mucosal Vaccine Delivery Vehicle Targeting Colorectal Cancer
por: Alias, Nur Aqlili Riana, et al.
Publicado: (2023) -
Development of a single-chain fragment variable fused-mutant HALT-1 recombinant immunotoxin against G12V mutated KRAS colorectal cancer cells
por: Teo, Michelle Yee Mun, et al.
Publicado: (2021) -
KRAS(G12C)-independent feedback activation of wild-type RAS constrains KRAS(G12C) inhibitor efficacy
por: Ryan, Meagan B., et al.
Publicado: (2022) -
Feedback activation of EGFR/wild-type RAS signaling axis limits KRAS(G12D) inhibitor efficacy in KRAS(G12D)-mutated colorectal cancer
por: Feng, Juanjuan, et al.
Publicado: (2023)